PMID- 25391998 OWN - NLM STAT- MEDLINE DCOM- 20150924 LR - 20220408 IS - 1471-2334 (Electronic) IS - 1471-2334 (Linking) VI - 14 DP - 2014 Nov 13 TI - Catheter-related Candida bloodstream infection in intensive care unit patients: a subgroup analysis of the China-SCAN study. PG - 594 LID - 10.1186/s12879-014-0594-0 [doi] LID - 594 AB - BACKGROUND: In patients hospitalized in intensive care units (ICU), Candida infections are associated with increased morbidity, mortality and costs. However, previous studies reported confused risk factors for catheter-related Candida bloodstream infection (CRCBSI). The objective was to describe the risk factors, microbiology, management and outcomes of CRCBSI in the China-SCAN population. METHODS: Patients with >/=1 Candida-positive peripheral blood culture were selected from the China-SCAN study. Peripheral and catheter blood samples were collected for Candida isolation. Patients with the same strain of Candida in peripheral and catheter blood samples were considered as being with CRCBSI, while patients with Candida-positive peripheral blood cultures only or different strains were considered as non-CRCBSI. Data were collected from the China-SCAN study. RESULTS: CRCBSI incidence in ICU was 0.03% (29/96,060), accounting for 9.86% of all candidemia observed in ICU (29/294). The proportion of CRCBSI due to Candida parapsilosis reached 33.3%, more than that of Candida albicans (28.6%). In univariate analyses, older age (P=0.028) and lower body weight (P=0.037) were associated with CRCBSI. Multivariate analysis showed that the sequential organ failure assessment (SOFA) score was independently associated with CRCBSI (odds ratio (OR)=1.142, 95% confidence interval = 1.049-1.244, P=0.002). Catheter removal and immune enhancement therapy were often used for CRCBSI treatment. CONCLUSIONS: In China, CRCBSI was more likely to occur in old patients with low body weight. SOFA score was independently associated with CRCBSI. Candida parapsilosis accounted for a high proportion of CRCBSI, but the difference from non-CRCBSI was not significant. FAU - Hu, Bo AU - Hu B FAU - Du, Zhaohui AU - Du Z FAU - Kang, Yan AU - Kang Y FAU - Zang, Bin AU - Zang B FAU - Cui, Wei AU - Cui W FAU - Qin, Bingyu AU - Qin B FAU - Fang, Qiang AU - Fang Q FAU - Qiu, Haibo AU - Qiu H FAU - Li, Jianguo AU - Li J LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20141113 PL - England TA - BMC Infect Dis JT - BMC infectious diseases JID - 100968551 RN - 0 (Antifungal Agents) SB - IM MH - Adult MH - Aged MH - Aged, 80 and over MH - Antifungal Agents/therapeutic use MH - Candida/*isolation & purification MH - Candida albicans/isolation & purification MH - Candidemia/drug therapy/*epidemiology/microbiology MH - Candidiasis/drug therapy/*epidemiology/microbiology MH - Catheter-Related Infections/drug therapy/*epidemiology/microbiology MH - China/epidemiology MH - *Cross Infection MH - Female MH - Humans MH - Incidence MH - Intensive Care Units MH - Male MH - Middle Aged MH - Multivariate Analysis MH - Risk Factors PMC - PMC4234860 EDAT- 2014/11/14 06:00 MHDA- 2015/09/25 06:00 PMCR- 2014/11/13 CRDT- 2014/11/14 06:00 PHST- 2014/05/19 00:00 [received] PHST- 2014/10/28 00:00 [accepted] PHST- 2014/11/14 06:00 [entrez] PHST- 2014/11/14 06:00 [pubmed] PHST- 2015/09/25 06:00 [medline] PHST- 2014/11/13 00:00 [pmc-release] AID - s12879-014-0594-0 [pii] AID - 594 [pii] AID - 10.1186/s12879-014-0594-0 [doi] PST - epublish SO - BMC Infect Dis. 2014 Nov 13;14:594. doi: 10.1186/s12879-014-0594-0.